Anxiety, Phobias, Treatment and Associated Costs: A Review by Gray, David D.
Journal of Research in Philosophy and History 
Vol. 1, No. 2, 2018 
www.scholink.org/ojs/index.php/jrph 
ISSN 2576-2451 (Print) ISSN 2576-2435 (Online) 
125 
 
Original Paper 
Anxiety, Phobias, Treatment and Associated Costs: A Review 
David D. Gray1* 
1 Fielding Graduate University, Santa Barbara, CA., United States 
* David D. Gray, Fielding Graduate University, Santa Barbara, CA., United States 
 
Received: November 15, 2018 Accepted: November 20, 2018 Online Published: November 22, 2018 
doi:10.22158/jrph.v1n2p125  URL: http://dx.doi.org/10.22158/jrph.v1n2p125 
 
Abstract 
Anxiety disorders are the most commonly occurring mental disorders and understanding them is 
important. Learning theorists suggest that phobias, a type of anxiety disorder, are conditioned responses 
to unconditioned stimuli. Research supports the theory that extinction of these conditioned responses 
may actually be the learning of a new memory rather than the unlearning of an old memory. Mounting 
evidence also points to sleep as an important factor in learning and memory and research suggests that 
sleep plays a role in phobia-extinction. However, while the majority of evidence is supportive, it is far 
from all inclusive. Future research should be conducted to clarify the role that sleep plays in 
phobia-extinction. Sleep roles such as sleep latency, sleep duration, and sleep staging may all play a part 
in the process. 
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1. Introduction 
The National Institute of Mental Health, citing data from the Collaborative Psychiatric Epidemiology 
Surveys (CPES), estimates that over 19.1% of the adult population in the United States suffers from an 
anxiety disorder at some point during a 12-month period (Alegria, Jackson, Kessler, & Takeuchi, 2016). 
Anxiety disorders are also comorbid with substance abuse disorders and research suggests that these 
comorbidity rates may be as high as 33%-45% (Grant et al., 2006; Regier et al., 1990). Most of those 
suffering from a mental health condition remain untreated (Wang et al., 2005). Despite most not 
seeking or receiving treatment, the estimated cost of anxiety disorders to the United States was 
estimated to be over $42 billion dollars in 1999 (Greenberg et al., 1999; Kirk & Rouf, 2004). Inflation 
calculators suggest that $42 billion dollars in 1999 was equivalent to over $61 billion dollars in 2017. 
Research suggests that the numbers are much higher. Understanding of anxiety disorders and 
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efficacious treatment options are important to both provide services to those in need, and to contain 
rapidly expanding costs of mental health treatment.  
 
2. Anxiety Disorders 
Anxiety disorders are defined as “disorders that share features of excessive fear and anxiety and related 
behavioral disturbances” by the Diagnostic and Statistical Manual of Mental Disorders—Fifth Edition 
(DSM-5; American Psychiatric Association, 2013, p. 189). Anxiety disorders are distinct from normal 
developmental fear due to their persistence beyond normal developmental timeframes. For example, a 
young child might be appropriately afraid of a common house spider and run off. An adult that refuses 
to enter a room because there is a spider in it is more likely to suffer from a specific phobia. Due to 
subjective levels of fear and danger, it is often necessary for the clinician to determine if fear and 
behaviors are proportionate to the level of danger.  
The DSM-5 differs slightly from the Diagnostic and Statistical Manual of Mental Disorders—Fourth 
Edition—Text Revision (DSM-IV-TR) regarding anxiety disorders. The DSM-5 counts neither 
Obsessive-Compulsive Disorder (OCD) nor Posttraumatic Stress Disorder (PTSD) as anxiety disorders 
as the DSM-IV-TR did. Other changes have been made in the DSM 5; however, for the scope of this 
paper, only changes in specific phobias will be discussed below.  
2.1 Prevalence  
Kessler et al. (2005), using data from face-to-face, household surveys across a nationally representative 
sample (n = 9,282), found that anxiety disorders were the most common type of disorder (24.8%). The 
lifetime prevalence for specific phobias ranked third (12.5%) only behind major depression (16.6%) 
and alcohol abuse (13.2%). Kessler et al. (2005) stated that the numbers are likely “conservative” due 
to potential biases (p. 6). A possible limitation in this study was an unwillingness to participate in the 
surveys due to potential histories of mental illness or embarrassment.  
As previously stated, estimates suggest that 18.1% of the adult population in the United States suffers 
from an anxiety disorder at some point during a 12-month period (Kessler et al., 2005). The most 
prevalent 12-month disorder is specific phobias. During a 12-month period, specific phobias (8.7%) 
surpass even major depressive disorders (6.7%; Kessler et al., 2005). Again, this data was considered 
conservative by the authors due to the same potential biases reported in their study previously, namely 
unwillingness to participate (Kessler et al., 2005). 
A major limitation is the age of the studies. Since their publication, diagnostic criteria have changed. It 
is possible that attitudes towards mental health have changed as well. Perhaps more people are seeking 
treatment; perhaps fewer are. Unfortunately, these studies are based upon a rather large and expensive 
dataset. Collecting data with structured interviews and surveys is costly and it is unreasonable to expect 
more frequent data collections of this scale. However, more recent research using the same National 
Comorbidity Survey Replication (NCS-R) data was provided with negligible change noted (Kessler, 
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Petukhova, Sampson, Zaslavsky, & Wittchen, 2012). The National Institute of Mental Health (NIMH) 
uses this data to date.  
2.2 Health Care Costs  
As previously stated, it is believed that over 18% of the population suffers from an anxiety disorder 
during the course of a year (Kessler et al., 2005, 2012). However, the personal burden of the disability 
is often overlooked (Baxter, Vos, Scott, Ferrari, & Whiteford, 2013). The US Burden of Disease 
Collaborators (2013) found that in the period between 1990 and 2010, two of the top five contributors 
to Years Lived With Disability (YLDs) in the United States were major depressive disorder (#2) and 
anxiety disorders (#5). Globally, anxiety disorders were the sixth leading cause of disability (Baxter et 
al., 2013). YLDs are measurements of the burden of disease and are computed by multiplying the 
disorder’s prevalence by the loss of health associated with the disorder (Baxter et al., 2013; US Burden 
of Disease Collaborators, 2013). In 1990, anxiety disorders accounted for over 1.5 million YLD’s (95% 
UI 1.1-2.0 million), or just over five percent of the overall disease burden due to disability in the 
United States (US Burden of Disease Collaborators, 2013). By comparison, in 2010, anxiety disorders 
accounted for over 1.8 million YLD’s (95% UI 1.3-2.6 million), or over six percent of the overall 
disease burden due to disability in the United States, a 21.3% median change (US Burden of Disease 
Collaborators, 2013). The increase can largely be accounted for by population growth and the 
increasing age of the United States population (US Burden of Disease Collaborators, 2013). The costs 
of mental health treatment are also on the rise.  
In 2013, spending on mental health exceeded all other medical spending (Roehrig, 2016). Mental 
health spending accounted for $201 billion, a value significantly higher than the remaining top five 
medical conditions: heart conditions ($147 billion), trauma ($143 billion), cancer ($122 billion), and 
pulmonary conditions ($95 billion). Of that $201 billion dollars spent for mental health, over 40 
percent is spent on institutionalized populations (Roehrig, 2016). During the time-period 2002-2012, 
mental health was reported as accounting for the largest increase in medical spending, with spending 
increasing from $58.6 billion in 2002 (adjusted for 2012 inflation rate) to $83.6 billion in 2012 for 
civilian, noninstitutionalized populations (Soni, 2015). However, it should be noted that information 
from this source was contradictory. In a chart embedded in the Soni article, cancer expenditures 
increased by $27.7 billion while mental health expenditures increased by $25 billion. According to J. 
Rhoades (personal communication, April 10, 2018), the article was in error, making mental health the 
second largest expenditure in 2012. Mental health also saw the largest increase of people with 
associated expenditures. The number of people with mental health expenditures rose from 31.1 million 
to 45.2 million in 2002 to 2012 respectively (Soni, 2015).  
Anxiety disorders are the most often occurring mental disorder in the United States, yet there has been 
little research into the annual costs of anxiety disorders. Data from the 2009-2010 Medical Expenditure 
Panel Survey (MEPS) suggests that over 30 million people report an anxiety disorder diagnosis 
(Shirneshan, 2013). Direct costs for anxiety disorders were greater than $33.7 billion dollars in 2013. 
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Indirect costs were calculated by morbidity costs (the lost productivity of individuals with anxiety 
disorders) plus mortality costs (lost productivity calculated by subtracting age at death from life 
expectancy). Direct costs ($33.7 billion) plus indirect costs (morbidity, $12.7 billion; mortality, $2.3 
billion) equated annual costs in excess of $48 billion to society in the United States in 2013 
(Shirneshan, 2013).  
As stated, indirect costs were calculated by adding morbidity and mortality costs. Direct costs consist 
of medication prescriptions, in- and out- patient stays and visits, and emergency room visits 
(Shirneshan, 2013). As an example of direct costs, workers diagnosed with anxiety disorders were 
nearly five times as likely to see a psychiatrist and nearly fifteen times more likely to see a psychologist 
when compared to their peers without an anxiety disorder diagnosis (Marciniak, Lage, Landbloom, 
Duanayevich, & Bowman, 2004). Workers with diagnosed anxiety disorders were also admitted as 
inpatients for mental illness nearly seven times more often. In addition, workers with anxiety disorder 
diagnoses were more likely to see a gastroenterologist and to utilize hospital emergency rooms than 
their non-diagnosed peers (Marcinak et al., 2004). Utilization of services were not the only differences. 
Workers with anxiety had nearly twice as many unofficial absences, were two and a half times more 
likely to collect short-term disability and had one-and-a-half times the financial expenses of their peers 
(Marcinak et al., 2004). The above reported costs were broken down from mental health to anxiety 
disorders. Phobias are a type of anxiety disorder. However, the annual costs of phobias, particularly 
specific phobias, are unknown.   
 
3. Phobias 
A phobia is an intense, irrational fear. The DSM-IV-TR criteria for specific phobias included, (a) 
“marked and persistent fear that is excessive or unreasonable,” (b) “exposure to the phobic stimulus” 
that “provokes an immediate anxiety response,” (c) “the person recognizes that the fear is excessive 
and unreasonable,” (d) “the phobic situation(s) is avoided or else endured with intense anxiety or 
distress,” (e) the situation “interferes significantly” with the individual’s life, (f) “in individuals under 
age 18 years, the duration is at least 6 months,” and (g) the disturbance is not the result of “another 
mental disorder” (APA, 2000, pp. 449-450). The core criteria of specific phobias in the DSM-5 are 
largely the same. The DSM-5 removed the criteria requiring the subject to be aware that their fear and 
anxiety are excessive and, as stated, the clinician often determines if the fear is proportionate to the 
level of danger. A second change is that the 18 year-old age limit is now applicable to all ages rather 
than under eighteen (APA, 2013).  
There are five different types, or specifiers, of specific phobias. The first is a fear of animals. The 
animal category is broad and encompasses all animals, i.e., spiders, insects, mammals. The second 
category is the natural environment. This may include fear of storms, etc. The third is a fear of 
“blood-injection-injury”, i.e., a fear of needles (APA, 2013, p. 198). The fourth category is situational, 
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i.e., fear of flying, or public speaking. The fifth and final category is a general “Other” category which 
includes such things as a fear of clowns or a fear of loud sounds (APA, 2013, p. 198). 
3.1 Treatment Options 
There are multiple treatment options for phobias. Hofmann (2008) states that the most efficacious 
treatments include “exposure therapy with or without cognitive strategies” and psychopharmacology (p. 
200). Alpers (2010) states that exposure therapy without relaxation is “clearly” the gold standard 
treatment for specific phobias (p. 212). Otte (2011) stated that the gold standard treatment method for 
phobias is Cognitive Behavioral Therapy (CBT). Spiegel (2014), citing treatment failures/resistance 
and noncompliance with scheduled interventions, suggests that treatment of phobia could be improved 
with hypnosis. For purposes of this paper, exposure therapy will be the treatment modality discussed. 
The goal of exposure therapy is to extinguish the fear response to phobic stimuli. Exposure therapy is a 
cognitive intervention that changes the expectation of harm from phobic stimuli (Hofmann, 2008). 
Extinction is likely not forgetting one’s fear, but rather the learning of a new memory in which the 
previously feared stimuli does not engage the fear response (Hoffmann, 2008). In exposure therapy, 
new memories are learned by challenging existing harm expectations such as threat of physical or 
psychological harm in a controlled environment. Control, or lack thereof, in the presence of an aversive 
stimuli may be a factor in the development of a phobia with less control equating to more severe 
psychopathy. Conversely, control may be a mediating variable between psychopathology and treatment, 
and may be a key component involved in extinction, exposure therapy and CBT (Hoffmann, 2008). 
Imaginal exposure therapy involves confronting fear through visualization. Using the fear of public 
speaking as an example, a client using imaginal exposure would visualize themselves in front of and 
addressing a crowd. In vivo exposure therapy involves a client and a therapist in a largely controlled 
situation in which a patient directly confronts their fear in actual live situations via flooding (rapid 
exposure to a feared stimulus) or systematic desensitization (gradual exposure to a feared stimuli). For 
example, using the previous example of public speaking, an individual would address their fear by 
speaking in front of a crowd. In vivo exposure therapy often involves a gradual exposure to aversive 
stimuli under the care of their therapist. A client suffering from a fear of flying may learn techniques to 
manage their anxiety about flying, i.e., breathing and other relaxation techniques; they may receive 
psychoeducation about air travel, i.e., common occurrences such as turbulence, etc. Some clients and 
therapists may even meet at airports and work towards a flight at the end of treatment. Throughout all, 
the therapist is often present, acts as a model and provides a degree of control. However, in vivo 
therapy cannot be completely controlled. A spider may bite an arachnophobic patient that finally 
worked towards handling a spider; an elevator may breakdown after a client worked up the courage to 
enter the elevator; or, a client suffering from PTSD after a motor vehicle accident may be involved in 
another accident. 
A third method of exposure, virtual reality, or in virtuo exposure, allows the clinician to provide 
treatment in the safety of an office or a laboratory rather than exposing the client to the risks that may 
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be involved with in vivo exposure. A client with a fear of public speaking using in virtuo exposure would 
be immersed into a computer simulation in which they would see a virtual crowd of people before them. 
The client would then interact with the crowd virtually (Wiederhold & Wiederhold, 2014).  
 
4. Virtual Reality 
Virtual Reality (VR) is a tool that allows users to immerse themselves in a real time, 3D 
computer-generated simulation allowing interactions between themselves and a digital environ in 
which the imagery changes according to the user’s actions (Bouchard, 2011). For example, if users turn 
their head to look around a room, the image changes to accommodate the changed view. VR has long 
been used for training situations. However, it is only recently that the equipment has become affordable 
to clinical psychologists and clinical practice. Virtual Reality Exposure Therapy (VRET) has been 
found to be effective as a therapeutic tool (Perpina et al., 2013; Rus-Calafell, Gutierrez-Maldonado, & 
Ribas-Sabate, 2014) for a wide variety of psychological problems and disorders (Perpina et al., 2013) 
such as acute pain, anxiety disorders, attention-deficit disorders, autism spectrum disorders, changing 
maladaptive habits, cognitive impairments, eating disorders, Posttraumatic Stress Disorder (PTSD), 
rehabilitation, sex offending, and social skills intervention specific phobias (Bouchard, St-Jacques, 
Robillard, & Renaud, 2007; Bouchard, 2011; Cárdenas & De La Rosa, 2012; Cesa et al., 2013; Perpina 
et al., 2013; Rizzo et al., 2013; Rothbaum & Hodges, 1999; Rothbaum, Ruef, Litz, Han, & Hodges, 
2003; Rus-Calafell et al., 2014). In 2006, no studies of virtual reality and exposure therapy were found to 
be ineffective; in fact, only three studies at the time were found with weak effects (Bouchard, Côté, & 
Richard, 2006). There are studies that indicate that VRET works equally as well as traditional 
treatments (Bouchard & Wiederhold, 2014). Others indicate that VR provides optimal outcomes when 
used in conjunction with traditional treatments (Cesa et al., 2013; Perpina et al., 2013) while other 
studies show that in virtuo treatments work better than traditional therapies (Mühlberger, Wiedemann, 
& Pauli, 2003). 
4.1 Advantages  
Perhaps VRET’s greatest advantage is that it is under direct therapist control (Bouchard et al., 2007; 
Perpina et al., 2013). Unlike in vivo exposure, in virtuo exposure lessens or negates the risk of 
breaching confidentiality; it also lessens or negates the risk of an unforeseen exposure. For example, an 
elevator malfunction during in vivo exposure could traumatize a client that is being seen for 
claustrophobia or fear of heights. As the technology progresses and virtual reality becomes more 
affordable, VRET may become a more financially feasible method of treatment. A virtual environment 
would cost much less than in vivo exposure for clients that are being treated for fear of flying in 
addition to the added benefit of reducing the risk of potential harm that air travel adds.  
Another advantage of VRET is its ability to make individuals feel present in the virtual environment 
(Rothbaum & Hodges, 1999; Perpina et al., 2013). VRET participants can be engaged using all five of 
their senses thus making the simulation seem real (Perpina et al., 2013; Riva, Mantovani, & Bouchard, 
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2014). This immersion is what allows the participant to feel active and present within the environment 
recognizing the environment at meaningful rather than viewing the simulation from a third person 
perspective (Riva, Mantovani, & Bouchard, 2014). Participants not suffering from a phobia have also 
found that the virtual environments seem real. Studies have found that non-phobic individuals 
immersed into a phobic virtual environment have self-reported levels of arousal while phobic 
individuals immersed into the phobic environment have more intense fear reactions (Bouchard, Côté, & 
Richard, 2006). Motion tracking and physiological measures have also been used to record the fear 
response of non-phobic individuals (Bouchard, Côté, & Richard, 2006).  
4.2 Efficacy of VRET and Anxiety Disorders  
As previously stated, anxiety disorders are one of the most prevalent mental health disorders (Bouchard, 
2011; Rus-Calafell, Gutierrez-Maldonado, & Ribas-Sabate, 2014; Wiederhold B. & Wiederhold M., 
2014a). There are many subset conditions of anxiety disorders such as panic disorders, generalized 
anxiety disorders, and specific phobias (Satcher, 2000). Post-traumatic stress disorders, though no longer 
in the diagnostic manual as an anxiety disorder, do have features of anxiety and have been found to 
respond favorably to treatment for anxiety disorders. Estimates suggest that 8-9.1% of the adult 
population will be affected by at least one specific phobia over the course of a year (NIMH, 2017; Satcher, 
2000). Studies of aviophobia, the fear of flying, have found strong support for VRET, particularly when 
distal effects were measured (Mühlberger, Wiedemann, & Pauli, 2003; Wiederhold, Bouchard, & 
Loranger, 2014). Acrophobia, the fear of heights, is believed to be the second most common phobia 
behind animal phobias (Bouchard, Wiederhold, & Bossé, 2014). In a between-groups study of in vivo 
exposure therapy versus in virtuo exposure therapy, researchers in Amsterdam built exact likenesses of 
three environments in Amsterdam: a four-story mall, a 50 ft fire escape, and a roof top garden on a 
university building. Researchers found that virtual reality exposure was equally as affective as in vivo 
exposure (Emmelkamp et al., 2002), which not only highlights the efficacy of in virtuo exposure, but 
suggests promising implications in regards to the affordability of the equipment and the ease of use in 
clinical settings with limited access to environments to meet a range of client’s needs. 
One of the most exciting aspects of in virtuo exposure is its potential use for treating posttraumatic 
stress disorder due to the ability to tailor the environment to meet a client’s particular need (Wiederhold 
B. & Wiederhold M., 2014b). As an example, virtual reality has been used to treat PTSD in war 
veterans, survivors of the September 11, 2001 terrorist attacks at the World Trade Center, earthquake 
survivors, terrorist bus bombings, violent crime victims and/or witnesses, and motor vehicle accidents 
(Cárdenas & De La Rosa, 2012; Wiederhold B. & Wiederhold M., 2008). Recent conflicts have seen an 
increase in the number of overseas deployments for the military. Due to the military presence in Iraq 
and Afghanistan over the last 14 years, the United States military has looked at VRET as possible 
treatment for PTSD. In a clinical trial of virtual Iraq and Afghanistan, 20 active duty members 
completed VRET and achieved positive results (Rizzo et al., 2013). In fact, 80% of the members 
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treated no longer met criteria of PTSD at the follow-up assessment three months later (Rizzo et al., 
2013). 
Motor vehicle accidents affect millions of American drivers and are the most common cause of PTSD 
in the general population (Beck & Coffey, 2007; Blanchard & Hickling, 2004). In one study, VRET 
was offered over ten sessions to drivers involved in a motor vehicle accident within the last six months 
that were experiencing symptoms of PTSD such as intense fear and helplessness. The participants were 
assessed at pre-treatment and one month post-treatment with the CAPS, the Posttraumatic Stress 
Scale-Self Report (PSS-SR), the Impact of Event Scale-Revised, and the Beck inventories of anxiety 
and depression (BAI and BDI respectively). All of the scores were reduced from pre- to post-treatment 
(Beck & Coffey, 2007) again suggesting the efficacy of in virtuo exposure. As with many of the 
aforementioned studies, in virtuo exposure allows the clinician to provide treatment in the safety of an 
office or a laboratory rather than exposing the client to the risks that would be involved with in vivo 
exposure. 
A meta-analysis of 21 studies was conducted on the efficacy of VRET in treating anxiety and specific 
phobias that met their inclusion criteria. Inclusion criteria consisted of the use of interval or ratio data, 
symptoms present before and after VRET, use of an affective assessment instrument and results that 
included means and standard deviations to allow for calculating effect sizes. Many of the studies cited 
above were included in this meta-analysis. While noting some limitations such as small sample sizes 
and non-randomized trials, the author’s findings suggest that VRET is an effective tool for clinical 
psychologist (Parsons & Rizzo, 2007). 
It seems logical that the more one senses a virtual environment, the more likely one will feel immersed 
or present. As technology progresses, digital simulations improve subsequently enhancing sight and 
sound senses. Hardware improvements allow deeper immersion into the simulation with haptic 
feedback providing a sense of touch. Scent is now being introduced into VR providing an even more 
immersive setting.  
The “Proust phenomenon” is the theory that memories brought about by odors are more emotional than 
other memories. The Proust phenomenon is named after the French author, Marcel Proust, who 
described the feelings and memories that the smell of a favorite treat evoked (Herz, Eliassen, Beland, & 
Souza, 2004; Munyan III, Neer, Beidel, & Jentsch, 2016). Using functional Magnetic Resonance 
Imaging (fMRI), Herz and colleagues (2004) found greater amygdala and hippocampal activation in the 
presence of an odor that individuals related to personally. Another study found that verbal cues of Odor 
Evoked Autobiographical Memories (OEAMs) were found to activate areas of the brain associated 
with emotional processing even in the absence of a physical odor (Arshamian et al., 2013). Regarding 
the application of scent to virtual reality, researchers have found that self-reported levels of immersion 
and presence were higher with the introduction of scents and lower when scents were withheld 
(Munyan III et al., 2016). Research supports the efficacy of virtual reality as a medium for exposure 
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therapy. However, virtual reality research is largely conducted by a relatively small group of 
researchers. 
Possibly due to the relatively short time that virtual reality has been studied, or perhaps due to the small 
niche that it occupies, the research on virtual reality thus far has largely been carried out by select 
group of researchers. One only needs to look at the reference list in most of the articles to see the “big 
names” in virtual reality therapy. This tight group suggests the possible presence of allegiance; it is 
possible that the results were affected by the researcher’s allegiance to VRET. It would not be irrational 
to consider the financial benefits of some of the more prolific VRET researchers either. For example, 
two of the researchers have co-authored a book about virtual reality while another two researchers are 
the founders and co-owners of a virtual reality company that provides workshops and sells products 
related to virtual reality. However, the allegiance effect is likely very small, and research does suggest 
that virtual reality may be useful in forming new memory.  
 
5. Memory, Learning and Sleep 
As previously stated, extinction is believed to be the formation of a new memory rather than the 
unlearning of an old memory. Due to the ability of a phobia to be acquired in one encounter, along with 
its resistance to extinction, and likely non-cognitive component, phobias may be a prepared learning 
process with a potential evolutionary purpose. For example, fear or snakes, spiders and/or heights are 
common phobias that relate to survival and may thus be more easily acquired and readily learned. 
Seligman (1971) wrote that phobias are “highly prepared to be learned by humans”, “are probably 
non-cognitive” and stated that phobias are often “resistant to extinction” (p. 312). Unprepared learning 
(i.e., a loud noise or shock paired with the presentation of a light or color) often involves multiple trials 
to develop a fear response and is relatively easy to extinguish in a laboratory setting. Seligman’s 
Phobias and Preparedness (1971) led to a plethora of anxiety research including the acquisitions of 
fear pathways.  
According to research, fears and/or phobias may be acquired via (1) classical conditioning, (2) 
vicarious observation/learning (observing how one’s parents react towards a fear stimuli), (3) verbal 
transmission (one’s caregiver communicating danger regarding a fear stimuli), and (4) non-associative 
means (individual responses of varying degrees on a first encounter with a fear stimuli; McNally, 2016). 
Evolution may play a role in phobic acquisition, but it must be noted that not all who have suffered a 
spider or snake bite have acquired a phobia; conversely not all who suffer from an animal phobia have 
been harmed by their feared stimuli. Stress and/or emotion at the time of acquisition may play a role.  
During periods of stress, memory systems become less cognitive based and more rigid (Schwabe, Wolf, 
& Oitzl, 2010). Phobias are irrational fears and a kind of closed mind thinking; perhaps this is why 
phobias may be more resistant to extinction. The more profound the stress is, the more inflexible or 
rigid the memory may become. Stress is believed to affect memory encoding, memory consolidation 
and memory retrieval. Though there is variability in memory encoding research, the effects of stress on 
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memory encoding suggests that emotion accompanying the event can preserve or enhance memory 
encoding.  
Memory consolidation research suggests that hormones released through emotional arousal strengthen 
memories. The glucocorticoid cortisol is associated with stress and may interfere with memory and 
learning. However, the presence of glucocorticoids with basolateral amygdala activity, may produce 
memory enhancing effects. In the absence of co-occurring basolateral amygdala activity, memory 
consolidation is impaired (Schwabe et al., 2010). A study by Abercrombie, Speck and Monticelli (2006) 
found that only participants with a change in situational negative affect in conjunction with cortisol 
levels demonstrated improved recall; recall was not affected by baseline negative affect and cortisol 
levels suggesting that emotional arousal is necessary to facilitate memory consolidation. 
Research suggests a negative correlation between stress and memory retrieval. As stress rises, memory 
recall declines. Glucocorticoids and the basolateral amygdala are implicated in memory retrieval as 
well as in memory consolidation. However, in memory retrieval, inhibiting the basolateral amygdala 
improves memory retrieval. Corroborating studies have found that beta blockers also inhibit the 
negative effect of stress on memory retrieval (Schwabe et al., 2010).   
Memory theory has long held that the hippocampus and the amygdala are involved in memory and has 
been predominant since the epileptic surgery of Henry Molaison in the 1950s. During the surgery, Mr. 
Molaison’s hippocampus was damaged and he was unable to form new memories. Memories predating 
the surgery were still intact. Thus, the theory was that memory is formed in the hippocampus and then 
stored in the amygdala. However, research suggests that this theory is not entirely accurate. A recent 
study by Kitamura and colleagues (2017) found that the brain makes two memories of an event. Using 
mice in the study and optogenetics (light used to control neuronal activity), Kitamura et al. (2017) 
watched memories form in reaction to a shock. Rather than the memory forming in the hippocampus 
and transferring to the cortex, the hippocampus appeared to generate engram cells (cells that account 
for a permanent change in the brain) in the prefrontal cortex. The prefrontal memory did not appear to 
be active as it matured, and researchers were able to stop maturation of the engram cells if the 
connection between the hippocamps and the prefrontal cortex were blocked. However, researchers 
were able to switch the memories on and off, definitively showing its presence.  
Memory formation and consolidation are also affected by sleep. Sleep has been found to be beneficial 
to both conscious (declarative) and unconscious memory (procedural) processes; there is little to no 
empirical evidence that suggests sleep in any way impairs memory. In fact, research suggests that sleep 
deprivation impairs the memory formation. Sleep is believed to be especially vital to the consolidation 
of emotional memory. Naps as short as six minutes aid with memory retention with increased benefits 
for longer sleep duration (Diekelmann & Born, 2010). There are multiple theories about sleep and 
memory.  
The active system consolidation theory believes that newly encoded memories are repeatedly 
reactivated during Slow Wave Sleep (SWS). A sleep cycle consists of three Non-Rapid Eye Movement 
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(NREM) sleep stages (N1, N2, and N3) and a Rapid Eye Movement (REM) phase (Stage R; American 
Academy of Sleep Medicine, 2018). Sleep stage N1 marks a transition from wakefulness to sleep. 
Sleep stage N2 sleep is marked by a reduction in breathing and heart rate, and accounts for nearly half 
of an individual’s total sleep time. Sleep stage N3 is marked by SWS and is a regenerative period of 
sleep. REM sleep follows and is where dreaming occurs. The brain becomes very active during REM 
sleep, but the muscles are still relaxed. Periods of REM sleep become longer as sleep progresses, and a 
healthy sleeper will cycle through the four sleep stages and REM four to five times per night. 
Continually cycling through the stages of sleep allows for the continued reactivation of newly encoded 
memories thus strengthening the memory (Diekelmann & Born, 2010).  
The synaptic homeostasis hypothesis is a second theory that posits: (a) wake periods are connected to 
synaptic strengthening of previously used synapses (potentiation); (b) synaptic potentiation is a 
homeostatic function of slow wave activity (SWA); and (c) SWA is related to synaptic reduction, and 4) 
synaptic reduction is tied to benefits of sleep (Tononi & Cirelli, 2003, 2006). The theory holds that 
Slow Wave Activity (SWA) is related to synaptic processes that occurred during waking periods. 
Specifically, the more synaptic processes were active during waking periods, the more active SWA will 
be during sleep counteracting waking synapse activity, pruning what is not important but keeping what 
is important. There is controversy concerning the exact mechanisms involved surrounding the synaptic 
homeostasis hypothesis (Blanco et al., 2015; Born & Feld, 2012). Other studies have suggested that 
REM sleep may be involved, and further studies should include REM sleep.   
 
6. Conclusion 
Anxiety disorders are the most commonly occurring mental disorders and are estimated to be over $61 
billion dollars at today’s rate of inflation with most affected individual not seeking treatment. Due to 
shame, embarrassment and/or an unwillingness to participate in surveys, it is believed that that the 
number of individuals in the United States affected by an anxiety disorder may actually be much higher 
than estimated.  
Phobias, a common anxiety disorder, are intense, irrational fears that are often resistant to extinction. 
There are treatment options for phobias however. Exposure therapy is often considered a gold standard 
treatment modality for phobias and other anxiety disorders. Exposure therapy may be imaginal 
exposure, in vivo exposure or in virtuo exposure. In virtuo, or virtual reality, studies have shown that 
VRET may be as efficacious as other types of exposure. VRET allows for immersion and presence in a 
digitally simulated environment. This allows greater therapeutic control of the exposure session. 
Exposure therapy’s goal is to lead to extinction of the irrational fear. Extinction is the learning of a new 
memory rather than forgetting an old memory. Sleep enhances memory, particularly emotional 
memory.  
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